
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Ukrainian Army Converts E38 BMW 7-Series Into Multiple Rocket Launch Platform - 2
Best Amusement Park in Asia: Which One Is a Must-Visit - 3
Vote in favor of your Number one Kind of Shades - 4
Mother and Stepson Rescued After Being Swept Over 6 Miles in Paddleboarding Mishap - 5
I served on the expert committee that advised the government on new dietary guidelines – most of our recommendations were ignored
Figure out How to Adjust Your Handshake to Various Societies
Lilly, Novo lock horns in India's obesity drug race
When preventable infections turn deadly behind bars | The Excerpt
Watch South Korean startup Innospace attempt its 1st-ever orbital launch today
Remain Fit: Powerful Wellness and Work-out Schedules for a Better You
Court clears Beersheba assault suspect of link to Haymanut Kasau disappearance, extends detention
Orcas seen hunting great white sharks to eat their livers in drone footage recorded in Mexico
Figure out How to Explore Land Close to 5G Pinnacles
With Obamacare premium hikes, more people opting for no coverage or cheaper plans












